No./age (years)/sex/eye | Baseline BCVA | Best follow-up BCVA | 6-month BCVA |
---|---|---|---|
1/44/male/OD | LP | LP | LP |
2/57/male/OD | LP | LP | LP |
3/42/female/OS | LP | LP | LP |
4/34/male/OS | 20/20000 | 20/20000 | 20/20000 |
5/34/male/OS | 20/2000 | 20/400 | 20/2000 |
6/30/female/OD | 20/20000 | 20/2000 | 20/2000 |
7/29/male/OS | 20/20000 | 20/2000 | 20/2000 |
8/47/male/OS | LP | LP | LP |
9/26/male/OD | 20/20000 | 20/400 | 20/400 |
10/46/female/OS | LP | LP | LP |
11/32/male/OS | 20/20000 | 20/20000 | 20/20000 |